大麻使用障碍与初次全髋关节置换术后结局的关联:全国行政索赔数据库分析
本研究利用行政索赔数据库,将3,842例合并大麻使用障碍的初次全髋关节置换术患者与19,188例对照按年龄、性别及合并症1:5匹配。结果显示,大麻使用障碍患者住院时间更长(4天 vs 3天,p<0.0001),医疗并发症(23.0% vs 9.8%,OR 1.6;p<0.0001)和植入物相关并发症(16% vs 7.4%,OR 1.6;p<0.0001)发生率及风险更高,90天费用也更高($16,938.00 vs $16,023.00;p<0.0001)。
要点
- 大麻使用障碍患者THA术后平均住院时间较对照延长1天(4天 vs 3天,p<0.0001)。
- 医疗并发症(23.0% vs 9.8%,OR 1.6)和植入物相关并发症(16% vs 7.4%,OR 1.6)风险均显著增高。
- 90天平均费用显著更高($16,938.00 vs $16,023.00,p<0.0001),可供术前咨询参考。
核心结论
- 合并大麻使用障碍的初次全髋关节置换术患者住院时间更长、医疗及植入物相关并发症更多、90天费用更高。
研究设计与样本
- 基于全国行政索赔数据库的匹配队列分析,按年龄、性别及多种合并症以1:5比例匹配,共纳入23,030例患者(研究组3,842例,对照组19,188例)。
主要发现
- 研究组平均住院时间显著长于对照组(4天 vs 3天;p<0.0001)。
- 研究组医疗并发症发生率显著更高(23.0% vs 9.8%,OR 1.6;p<0.0001)。
- 研究组植入物相关并发症发生率显著更高(16% vs 7.4%,OR 1.6;p<0.0001)。
- 研究组90天平均费用显著更高($16,938.00 vs $16,023.00;p<0.0001)。
临床怎么用
- 骨科医生及其他医疗专业人员可据此向合并大麻使用障碍的患者咨询THA术后可能的住院延长、并发症增加及费用升高风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Although there is increasing legalization of the use of cannabis in the USA, few well-powered studies have evaluated the association between cannabis use disorder and outcomes following primary total hip arthroplasty (THA). Thus, the aim of this study was to determine whether patients who use cannabis and undergo primary THA have higher rates of in-hospital length of stay (LOS), medical complications, implant-related complications, and costs. METHODS: Using an administrative database, patients with cannabis use disorder undergoing primary THA were matched to a control group in a 1:5 ratio by age, sex, and various medical comorbidities. This yielded 23,030 patients (3,842 in the study group matched with 19,188 in the control group). The variables which were studied included LOS, 90-day medical complications, two-year implant-related complications, and 90-day costs of care. Mann-Whitney U tests were used to compare LOS and costs. Multivariate logistic regression analyses were used to calculate the odds ratios (ORs) of developing complications. RESULTS: We found that patients in the study group had a significantly longer mean LOS compared with the controls (four days vs three days; p < 0.0001).The study group also had a significantly higher incidence and odds of developing medical (23.0 vs 9.8%, OR 1.6; p < 0.0001) and implant-related complications (16 vs 7.4%, OR 1.6; p < 0.0001) and incurred significantly higher mean 90-day costs ($16,938.00 vs $16,023.00; p < 0.0001). CONCLUSION: With the increasing rates of cannabis use, these findings allow orthopaedic surgeons and other healthcare professionals to counsel patients with cannabis use disorder about the possible outcomes following their THA, with increased hospital stays, complications, and costs. Cite this article: Bone Joint J 2021;103-B(7 Supple B):111-115.
引用
- Vakharia RM, Mannino A, Salem HS, et al. The association between cannabis use disorder and the outcome following primary total hip arthroplasty : analysis of a nationwide administrative claims database. Bone Joint J. 2021. PMID: 34192906. doi:10.1302/0301-620X.103B7.BJJ-2020-2424.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。